During the second International Conference on Podoconiosis held in Kigali on January 23, 2025, experts from 12 countries shared experiences and research aimed at eradicating podoconiosis globally.
The theme of this year’s conference, “From Neglected to Elimination with Country Ownership,” was chosen to align with the priorities outlined in the World Health Organization’s roadmap for neglected tropical diseases (NTDs). This theme underscores the importance of shifting the global narrative surrounding podoconiosis, transforming it from a neglected condition into one actively targeted for elimination through strong leadership and commitment from endemic countries.
Ladislas Nshimiyimana, Director of NTDs Unit at Rwanda Biomedical Center (RBC), emphasized the importance of collaboration in addressing podoconiosis: “We have seen the value of working with different partners. Through collaboration, we learn from each other, leading to better planning and more effective solutions,” he said.
Research conducted in 2018 estimated that Rwanda has 6,000 podoconiosis patients. To support them, around 13 treatment centers, including those at public health facilities and partner organizations, have been established. However, Nshimiyimana noted that progress is still limited: “We are not treating as many patients as we should. Only 1,311 individuals have received treatment so far. More efforts are needed, particularly in expanding services to all health facilities and building the capacity of healthcare providers to ensure better care,” he added.
In the fiscal year 2023-2024, Rwandan government allocated 31 million Rwandan Francs for the treatment of NTDs, including podoconiosis. The goal is to increase this budget and expand services to all health facilities across the country.
Podoconiosis cases found in Rwanda is a slowly progressing disease, caused not by a parasite, but by long-term exposure to irritant soils, particularly the red clay soils found in volcanic regions. The disease can be managed if treated early, allowing patients to recover and improve their quality of life. However, ongoing care is essential. Individuals must continue to protect their legs, wear shoes, perform physical exercises, and seek medical attention when necessary.
As of now, 1,311 people in Rwanda have been treated and are doing better. However, Ladislas Nshimiyimana stressed the need for continued efforts and resources to ensure long-term success.
Professor Gail Davey, from Brighton and Sussex Medical School and Director of Footprint (which organized the conference), shared an optimistic outlook: “The good news is that the communities in the 12 countries represented at this conference are the ones who understand podoconiosis the most and are working towards solutions,” she said. “While patients face challenges such as painful swelling, mental health issues, social and economic consequences, podoconiosis is preventable and treatable. It’s a simple solution: consistent use of shoes and concrete floors can make a significant difference.”
Podoconiosis is a debilitating condition affecting millions in more than 15 countries across Africa, Central America, and Asia. People suffering from podoconiosis are often unable to work, walk, or participate in daily activities and may face stigma and ostracization from their communities.
Through continued collaboration, awareness, and dedicated efforts from both governments and partners, Rwanda is set to eliminate podoconiosis by 2030, ensuring that future generations live free from this preventable and treatable disease.(End)